Neurocrine Biosciences Inc (NBIX)
134.65
-0.77
(-0.57%)
USD |
NASDAQ |
Dec 23, 11:32
Neurocrine Biosciences Total Liabilities (Quarterly): 816.10M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp | 813.96M |
| West Pharmaceutical Services Inc | 923.00M |
| AptarGroup Inc | 2.072B |
| The Cooper Companies Inc | 4.232B |
| AIM ImmunoTech Inc | 10.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.535B |
| Shareholders Equity (Quarterly) | 2.719B |
| Current Ratio | 4.367 |
| Net Debt Paydown Yield | 0.29% |